Section on Gynecology & Obstetrics. (Abstracts of Scientific Posters).

GYN/OB1-B. THE PERSONAL DIGITAL ASSISTANT (PDA) IN AN OBSTETRICS AND GYNECOLOGY RESIDENCY PROGRAM. Saju joy, MD, and Guy Benrubi, MD. Department of Obstetrics & Gynecology, University of Florida Health Science Center, Jacksonville, FL.

Improvements in electronic technologies have resulted in smaller devices at faster speeds. Whether the provision of a personal digital assistant (PDA) to obstetrics & gynecology residents enhances their residency experience is open to question. This paper presents our institutional experience with incorporating a PDA into an obstetrics and gynecology residency training program. A PDA (Handspring Visor TM) was provided to residents who did not currently have a PDA. They were then instructed to use this tool at their own leisure with no requirements imposed from the department. Surveys were conducted at three intervals to determine if this tool was impacting residency experience. Resident responses to the survey revealed that there was a decreased perceived value to this tool at follow up intervals. However, residents felt they were not utilizing this tool to its maximum potential. In 94% of responses, the responder felt that the PDA should be available at residency programs, and they anticipated using it in pr ivate practice after completing residency. Expectations for the potential uses of a PDA were high among the obstetrics and gynecology residents. However, the voluntary implementation of a new tool added an additional responsibility in an otherwise busy residency training program. Thus, the integration of the PDA did not meet the anticipated expectations of overwhelming use by residents. Providing additional software applications and PDA tutorials may encourage residents to take advantage of tools available for procedure logs, electronic billing, electronic prescriptions and wireless fetal monitoring.

GYN/OB2-B. METASTATIC UTERINE PAPILLARY SEROUS CARCINOMA ORIGINATING FROM AN ENDOMETRIAL POLYP. Alex J. Childs, MD, James J. Burke II, MD, Michelle Y. Perry, MD, and Donald G. Gallup, MD. Memorial Health University Medical Center, Mercer University School of Medicine, Savannah, GA.

Carcinoma of the endometrium is the most common cancer of the female genital tract. Two histologic variants of endometrial carcinoma have been described: an estrogendependent form and a more aggressive, nonestrogen form, which includes clear cell and uterine papillary serous carcinomas (UPSC). We present two cases of UPSC that were confined to an endometrial polyp without myometrial invasion, and were found to be widely metastatic. One of the patients presented with a four-month history of abdominal pain and constipation, while the other patient was asymptomatic; neither patient had vaginal bleeding, but both had CA-125 levels greater than 80 U/mL. At the time of surgery, both patients were found to have extensive carcinomatosis of the abdomen and pelvis. Both patients underwent hysterectomies with bilateral salpingo-oophorectomies, omentectomies, and bowel resections with anastomoses. Pathology reports from both patients showed that metastatic disease originated from a small focus of papillary serous adenoca rcinoma at the tip of an endometrial polyp. Further treatment for these patients will consist of combination chemotherapy. These cases emphasize the aggressive nature of uterine papillary serous carcinoma, despite minimal symptoms, no vaginal bleeding, and insignificant myometnal invasion.

GYN/0B3-B. OVARIAN SEX-CORD STROMAL TUMORS. Natash Hardeman, MD, and William J. Buder, MD, Mercer University School of Medicine, Savannah, GA.

Sertoli-Leydig cell tumors (SLGTs) and steroid cell tumors, not otherwise specified (NOS), are rare sex-cord tumors. Most are benign and occur unilaterally. These tumors usually secrete androgens. They often occur in young women who show signs of virilization. Clinical management is based on the histologic differentiation. Herein, the authors describe a case of a Sertoli-Leydig cell tumor and a steroid cell tumor, NOS. The presentation and clinical management of both tumors are discussed.